Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesA phase II clinical trial to assess the safety of clonidine in acute organophosphorus pesticide poisoning
Trials, 08/26/09
Perera PMS et al. – The findings suggest use of moderate doses of clonidine in acute organophosphate poisoning can be used without causing frequent clinical problems but that higher doses are associated with a high incidence of hypotension requiring intervention.
Related Articles
Clonidine versus Withdrawal Using an Opioid in In-Patient Opioid Detoxification
European Addiction Research, 11/16/09
Relevance Score: 87%
Influence of Clonidine on Bilateral Cervical Plexus Block using 0.25% Bupivacaine for Postoperative Analgesia following Thyroid Surgery
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Relevance Score: 87%
A comparative study between bupivacaine and clonidine associated with bupivacaine in cervical plexus block for carotid endarterectomy
Revista Brasileira de Anestesiologia, 10/02/09
Relevance Score: 84%
Co-analgesics - today and tomorrow - A receptor-based overview of therapeutical options
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 11/17/09
Relevance Score: 80%
Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery
Cochrane Reviews, 10/20/09
Relevance Score: 77%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Clinical Review of Echinocandins in Pediatric Patients
Annals of Pharmacotherapy, 12/16/09
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09
Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor